Linaclotide 290 micrograms
Idiopathic Pulmonary Fibrosis
Clinical trials
2
Developer
University of Nottingham
Overview
Linaclotide 290 micrograms is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 2 tracked IPF clinical trials.
Linaclotide 290 micrograms clinical trials
Explore related
Medical disclaimer. This page summarizes research about Linaclotide 290 micrograms for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.